Patent intelligence · US
US 11547670
Delayed release methylphenidate compositions
Delayed release methylphenidate compositions
Patent details — US 11547670
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 10, 2023
- Expiration
- Jan 5, 2043
- Applicant
- Amneal Complex Products Research LLC
- Claims
- 18
- CPC classes
- A61K, A61K31/135, A61K31/165, A61K31/4045
Quick answer
US 11547670 (Delayed release methylphenidate compositions) is held by Amneal Complex Products Research LLC. Status: granted. Granted Jan 10, 2023. Expires Jan 5, 2043 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Amneal Complex Products Research LLC
- Grant date
- Expiration
- Claims
- 18
- CPC classes
- A61K, A61K31/135, A61K31/165, A61K31/4045, A61K31/4168, A61K31/4402
More from Amneal Complex Products Research LLC
Related pharmaceutical patents in our USPTO index.
-
US 12383522
Baclofen formulations and methods of minimizing patient exposure to metabolite variations
granted -
US 12370163
Levodopa dosing regimen
granted -
US 12303482
Levodopa dosing regimen
granted -
US 12303481
Levodopa dosing regimen
granted -
US 12295931
Levodopa dosing regimen
granted -
US 12263149
Levodopa dosing regimen
granted -
US 12263148
Levodopa dosing regimen
granted -
US 12233166
Extended release compositions comprising pyridostigmine
granted
Frequently asked questions
What is US patent 11547670?
US 11547670 (Delayed release methylphenidate compositions) is held by Amneal Complex Products Research LLC. Status: granted. Granted Jan 10, 2023. Expires Jan 5, 2043 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11547670?
Amneal Complex Products Research LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 32 pharmaceutical patents for this assignee.
When does US 11547670 expire?
Our index shows an expiration date of Jan 5, 2043 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.